5Frisc Study Group. Low - molecular - weight hearin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet, 1996, (347):561.
6Husted SE, Wallentin L, Lagerqvist B, et al. Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization. Eur Heart J,2002 23(15):1213.
8Yang D,Morris SF. Comparison of two different delay procedures in a rat skin flap model. Plast Reconstr Surg, 1998,102:1591-1597.
9Zhou ZY,Nichter LS,West BR,et al. Evaluation of a temporary arteriovenous shunt to establish neovascularization in a musculocutaneous flap: an experimental study.Microsurgery.1994,15: 63-67.
10Nillson VA,Haraldsoon G,Bratell S,et al. ESR-measurement of oxygen radical in vivo after renal ischemia in the rabbit;effects of pretreatment with superoxide dismutase and heparin. Acta Physiol Scand, 1993,147:263-270.
